The resultant mice with germline deletion of Tet2 are viable and fertile but develop a CMML-like disease with leukocytosis, neutrophilia and monocytosis along with increased bone marrow cellularity, splenomegaly, and moderate liver enlargement. This evidence concerns the gene TET2 and chronic myelomonocytic leukemia.